NCT00381667
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Clayton, Victoria, Australia
- GSK Investigational Site Wellington, New Zealand
Clinical trial condition
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
NCT00381667
NCT00103922
NCT01691885
NCT01943552
NCT02441725
NCT00325169
NCT00595114
NCT01355978
NCT01347931